Altamir SCA (LTA.PA): BCG Matrix

Altamir SCA (LTA.PA): BCG Matrix [Apr-2026 Updated]

FR | Financial Services | Asset Management | EURONEXT
Altamir SCA (LTA.PA): BCG Matrix

Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets

Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur

Pré-Construits Pour Une Utilisation Rapide Et Efficace

Compatible MAC/PC, entièrement débloqué

Aucune Expertise N'Est Requise; Facile À Suivre

Altamir SCA (LTA.PA) Bundle

Get Full Bundle:
$9 $7
$9 $7
$9 $7
$9 $7
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Altamir's portfolio is bifurcated between high-growth Stars-Tech & Telco (38% of NAV) and Healthcare (22%)-that attract nearly half of new capital, and Cash Cows-services (25%) and mature funds (15%)-that fund dividends and liquidity; meanwhile Question Marks like the €120m Apax XI commitment and a nascent ESG sleeve need heavy follow-on investment to scale, and Dogs (legacy retail and small minority manufacturing stakes under ~3.5% combined) are slated for exit to free capital for the growth engines-read on to see how this mix drives Altamir's allocation strategy and risk-return profile.

Altamir SCA (LTA.PA) - BCG Matrix Analysis: Stars

Stars

The Tech & Telco and Healthcare & Life Sciences sectors within Altamir's portfolio qualify as 'Stars' under the BCG Matrix: high market growth and high relative market share/portfolio importance. These segments combine strong organic growth, high margins or reinvestment intensity, dominant mid-market positions in Europe, and outsized capital allocation from Altamir aimed at sustaining leadership and scaling exits.

Tech and Telco segment drives growth

The Tech & Telco segment represents 38% of Altamir's total portfolio value as of December 2025. Underlying companies in this digital-first sector achieved an average organic revenue growth of 18% over the last fiscal year. EBITDA margins for these software-heavy assets remain robust at approximately 28% due to high scalability and recurring revenue models. Altamir has allocated 45% of its new capital commitments to this sector to maintain its dominant market position in the European mid-market. The return on investment for realized exits in this category has consistently exceeded a 3.0x multiple of invested capital during the 2025 cycle.

Metric Value Notes
Portfolio share (Dec 2025) 38% Share of total portfolio value
Average organic revenue growth (FY 2025) 18% Weighted average across Tech & Telco assets
Average EBITDA margin 28% Driven by SaaS/recurring models
Share of new capital commitments (2025) 45% Targeted to sustain growth and M&A
Realized exit MOIC (2025 cycle) >3.0x Consistent realized multiple on exits

Healthcare and Life Sciences show gains

Healthcare assets account for 22% of Altamir's net asset value following strategic acquisitions throughout 2024 and 2025. The global market for specialized medical services and health technology is expanding at a CAGR of 12%. Within Altamir's portfolio, these assets have delivered a 15% increase in fair value over the preceding twelve-month period. CAPEX levels for companies in this segment remain elevated at roughly 10% of revenue to fund essential R&D and geographic expansion, including targeted entry into North American markets. As of year-end 2025 the segment retains a leading market share within the specialized European private equity landscape.

Metric Value Notes
NAV share (Dec 2025) 22% Post-acquisition weighting in portfolio
Global market CAGR 12% Specialized medical services & health tech
Fair value change (12 months) +15% Appraisal-driven increase across assets
Average CAPEX intensity 10% of revenue R&D and geographic expansion spend
Relative market position Leading in European PE specialized segment Position at YE 2025
  • High reinvestment: 45% of new capital to Tech & Telco, 10% CAPEX intensity in Healthcare supports both scale and innovation.
  • Attractive unit economics: Tech EBITDA ~28% enabling strong cash generation and funding for organic and inorganic growth.
  • Exit track record: Tech exits >3.0x MOIC in 2025 cycle underlines realized value creation potential.
  • Market exposure: Combined 60% portfolio weighting (38% Tech + 22% Healthcare) concentrates Altamir in high-growth, high-share domains.
  • Geographic expansion: Healthcare push into North America increases addressable market and exit optionality.

Altamir SCA (LTA.PA) - BCG Matrix Analysis: Cash Cows

Cash Cows

The services sector provides stable cash flows.

The services and distribution segment constitutes 25% of the total portfolio and serves as the primary source of liquidity for the firm. These mature assets generate steady annual cash flows that support a dividend payout ratio of nearly 50% to the parent company. Market growth in this traditional sector has stabilized at a modest 3% per year, reflecting its mature and consolidated status. The average EBITDA margin is consistent at 15%, requiring minimal reinvestment or CAPEX to maintain current operations. Altamir utilizes these reliable distributions to fund a 5% dividend yield for its own public shareholders on the Euronext Paris.

Legacy funds deliver consistent capital returns.

The Apax MidMarket VIII and IX funds are now in their harvest phase and represent 15% of the total asset base. These funds have reached a high level of maturity with a cumulative internal rate of return exceeding 15% since their initial inception. Annual distributions from these specific fund vintages provided 80 million euros in liquidity during the 2025 fiscal year. Market share in the French mid-market remains high for these established funds, even though new growth opportunities are naturally limited by their age. The low CAPEX requirement for these fully invested funds allows for maximum capital recycling into newer, high-growth opportunities.

Metric Services & Distribution Apax MidMarket VIII & IX
Portfolio share 25% 15%
Role in portfolio Primary liquidity generator / recurring cash Harvest-stage capital returns
Market growth (annual) ~3% ~2-3% (mature mid-market)
Average EBITDA margin 15% Not applicable (fund-level distributions; underlying companies variable)
Reinvestment / CAPEX requirement Low - maintenance-level CAPEX Minimal - funds fully invested
Dividend payout to parent ~50% of segment cash flows Distributions directed to parent / LPs
2025 annual liquidity contribution Material (see segment share) €80,000,000
Cumulative IRR - >15%
Contribution to Altamir public dividend Supports ~5% dividend yield Supports distributions/recycling into growth investments

Key operational and financial implications

  • Cash generation: Services segment produces predictable free cash flow due to 15% EBITDA margins and low reinvestment needs.
  • Liquidity: Legacy fund distributions (Apax VIII/IX) supplied €80m in 2025, enabling capital recycling and parent dividends.
  • Dividend capacity: Combined cash cows underpin a near-50% payout to the parent and a public yield of ~5% on Euronext Paris listing.
  • Limited organic growth: Market growth at ~3% means focus is on margin preservation and cash extraction rather than expansion.
  • Reinvestment strategy: Low CAPEX frees capital to fund higher-growth "Question Marks" or cover strategic M&A.
  • Risk profile: Mature assets reduce volatility but increase dependency on successful redeployment of cash into higher-return opportunities.

Altamir SCA (LTA.PA) - BCG Matrix Analysis: Question Marks

Question Marks - New global fund commitments require investment: Altamir has committed €120,000,000 (120 million euros) to the Apax XI global fund, representing 4.0% of Altamir's reported net asset value (NAV) of €3,000,000,000 as of the latest reporting period. Apax XI targets high-growth sectors with total addressable market (TAM) expansion >20% CAGR. The fund is in an early-stage deployment phase: current realized ROI is neutral (≈0% realized IRR to date), with unrealized value subject to portfolio company performance. Anticipated capital calls are estimated at €80-€100 million over the next 36 months, constituting a significant CAPEX-equivalent obligation against Altamir's balance sheet and liquidity. Vintage market share for Apax XI is currently low (estimated <1% share within Altamir-managed private equity exposure) but is projected to scale quickly as bolt-on and platform acquisitions complete.

Question Marks - ESG and Impact Investing seek share: Altamir's newly formed ESG-focused portfolio accounts for 2.8% of total asset allocation (≈€84,000,000 of the same €3.0bn NAV). This segment benefits from strong tailwinds driven by European regulatory mandates and accelerating green energy demand, with estimated market growth ≈25% CAGR. Current platform-level operating margins are compressed at ~8% due to upfront technology, reporting, and compliance investments. Altamir's market share in specialized impact private equity remains fragmented-estimated at <0.5% of the European impact PE market-relative to larger global competitors. Initial ROI for the ESG portfolio currently trails Altamir's broader portfolio average return on invested capital (ROIC) of ~12% (ESG current ROIC ≈6-7% on an interim basis), reflecting elevated setup costs and longer time-to-scale.

The combined profile of these Question Marks aligns them with the BCG Matrix 'Dogs' context when short-term market share and margins are low relative to peers and capital intensity is high; however, both initiatives display high market growth potential, creating strategic ambiguity. Key financial and operational metrics are summarized below to aid portfolio allocation decisions and scenario analysis.

MetricApax XI (Global Fund)ESG / Impact Portfolio
Altamir Commitment (€)120,000,00084,000,000
% of Altamir NAV4.0%2.8%
Current Realized ROI / IRR≈0% (realized, early-stage)≈6-7% (interim)
Portfolio Margin / Platform EBITDAN/A (early-stage, variable)≈8%
Estimated Market Growth (CAGR)>20%≈25%
Projected Additional Capital Calls (€ next 3 yrs)80,000,000-100,000,00040,000,000-60,000,000 (expansion & build-out)
Current Market Share (segment)<1% within Altamir PE exposure<0.5% in European impact PE
Time to Scale / Monetization3-7 years4-8 years
Exit Horizon Assumption5-10 years5-10 years

Strategic considerations and operational actions relevant to these Question Marks include:

  • Monitor and model cash flow timing for capital calls: prepare liquidity buffers of €150-€180 million over 36 months covering committed calls and contingency.
  • Track valuation milestones: set quarterly KPIs for portfolio companies (revenue growth %, ARR, EBITDA margin expansion) to trigger follow-on investments or harvest options.
  • Assess margin recovery levers: quantify cost-to-serve improvements and synergies targetable within 18-36 months to lift ESG margins from 8% toward portfolio average.
  • Market share scaling: target bolt-on acquisition cadence of 6-10 add-ons for Apax XI vintage to materially increase relative share within 3 years.
  • ESG regulatory arbitrage: allocate ~€5-10 million to compliance systems and reporting infrastructure to capture subsidy and tax incentives and accelerate fundraising.
  • Return thresholds: define minimum prospective IRR hurdles (e.g., >15% gross) before committing incremental capital beyond announced calls.

Risk and sensitivity items with quantifiable impacts:

  • Capital call timing variance ±6 months can change liquidity needs by €20-€30 million and affect leverage ratios (debt/EBITDA) by 0.1-0.3x.
  • Market growth slower-than-expected (20% → 12% CAGR) could reduce exit multiples by ~15-25%, lowering projected NAV uplift by an estimated €25-€60 million across these commitments.
  • Margin improvement delays of 24 months extend payback periods by ~1.5-2 years and reduce IRR by 200-400 basis points in modeled scenarios.
  • Concentration risk: combined exposure of ~6.8% of NAV to early-stage/high-growth bets increases portfolio volatility (expected VaR uptick ~+0.6% to +1.2% at 95% confidence depending on correlation assumptions).

Operational KPIs to monitor monthly / quarterly:

  • Capital call utilization rate (%) and remaining unfunded commitment (€)
  • Portfolio revenue growth rate (3-, 12-, 24-month rolling)
  • EBITDA margin progression by vehicle and aggregated for the strategy
  • Net asset value (NAV) mark-to-market % change and unrealized gain/loss
  • Fundraising traction for ESG initiatives (LP commitments € and number of new investors)

Altamir SCA (LTA.PA) - BCG Matrix Analysis: Dogs

Dogs - Traditional retail holdings face structural decline

Residual holdings in the traditional brick-and-mortar retail sector now represent 1.8% of Altamir's total portfolio value (€18.0m of a €1,000m portfolio). This segment's market growth rate is -4.0% annually as consumer migration to e-commerce accelerates. EBITDA margins have compressed to 5.0% (down from 9.5% three years ago). Current exit multiples observed in the market are 6.0x EV/EBITDA vs. historical 8.5x, reducing realizable valuations. The ROI for these holdings has averaged 0.8% over the last 12 months, trailing the broader portfolio return by ~10 percentage points (portfolio ROI ~10.8%). Altamir's stated objective is active divestment to reduce capital drag and administrative burden.

Metric Value Notes
Portfolio weight 1.8% €18.0m of €1,000m NAV
Market growth rate -4.0% p.a. Structural decline vs e-commerce
EBITDA margin 5.0% Contracted from 9.5% in 3 years
Exit multiple (EV/EBITDA) 6.0x Market observed
ROI (12 months) 0.8% ~10 pp below portfolio average
Administrative & holding cost €0.9m p.a. Includes leases, taxes, maintenance

Key operational and financial constraints include low free cash flow generation (€0.9m FCF aggregate), high working capital absorption (average DSO 68 days), and limited synergies with Altamir's growth platforms. Current valuation stress and limited buyer appetite imply potential sale proceeds could be discounted by 10-25% vs. book value, depending on timing and packaging.

  • Aggregate FCF: €0.9m (last 12 months)
  • Average DSO: 68 days
  • Potential valuation haircut: 10-25% vs. book
  • Target action: divestment within 12-24 months

Dogs - Non-core minority European stakes show limits

Non-core minority positions in European manufacturing account for 1.5% of NAV (€15.0m of €1,000m NAV). Market expansion for these niche manufacturing segments is ~1.0% p.a., and the portfolio companies hold <2.0% market share in their respective niches. ROI on these stakes has averaged 2.0% over the past three years, below Altamir's weighted average cost of capital (~6.5%). CAPEX has been limited to essential maintenance only (€0.6m p.a. aggregate), consistent with a managed, phased exit to redeploy capital into higher-growth Stars.

Metric Value Notes
Portfolio weight 1.5% €15.0m of €1,000m NAV
Market growth rate 1.0% p.a. Low-growth European manufacturing
Altamir's market share <2.0% Minority, non-control positions
Average ROI (3y) 2.0% Below WACC (6.5%)
CAPEX (maintenance) €0.6m p.a. Restricted spend
Planned action Phased exit Reallocate to Stars / growth assets

Constraints include illiquidity of minority stakes, limited strategic control to accelerate turnaround, and modest dividend yield (avg. 1.2% p.a.). Exit paths considered: structured sales to strategic buyers, block trades with conditional earn-outs, or portfolio pooling to enhance scale for sale. Expected recovered capital is projected at €12-14m after transaction costs and minority discounts (implying 7-20% haircut vs. carrying value).

  • Aggregate NAV: €15.0m
  • Expected recovery range: €12-14m
  • Dividend yield: 1.2% p.a. (average)
  • Recommended CAPEX: restricted to essential maintenance (€0.6m p.a.)

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.